Efficacy Evaluation of Tissue Inhibitor of Metalloproteinases-2 and Endostatin on Angiogenesis
![]() |
Kim, Soo-Hyeon
(Department of Molecular Bioscience, College of Biomedical Science, Kangwon National University)
Cho, Young-Rak (Department of Molecular Bioscience, College of Biomedical Science, Kangwon National University) Yoon, Hyun-Jae (Department of Molecular Bioscience, College of Biomedical Science, Kangwon National University) Ko, Hee-Young (Department of Molecular Bioscience, College of Biomedical Science, Kangwon National University) Kim, Pyeung-Hyeun (Department of Molecular Bioscience, College of Biomedical Science, Kangwon National University) Seo, Dong-Wan (Department of Molecular Bioscience, College of Biomedical Science, Kangwon National University) |
1 | Kerbel, R. and Folkman, J. : Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer 2, 727 (2002). DOI ScienceOn |
2 | Hoegy, S. E., Oh, H. R., Corcoran, M. L. and Stetler- Stevenson, W. G. : Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition. J. Biol. Chem. 276, 3203 (2001). DOI ScienceOn |
3 | Seo, D. W., Kim, S. H., Eom, S. H., Yoon, H. J., Cho, Y. R., Kim, P. H., Kim, Y. K., Han, J. W., Diaz, T., Wei, B. Y. and Stetler- Stevenson, W. G. : TIMP-2 disrupts FGF-2-induced downstream signaling pathways. Microvasc. Res. 76, 145 (2008). DOI ScienceOn |
4 | Oh, J., Seo, D. W., Diaz, T., Wei, B., Ward, Y., Ray, J. M., Morioka, Y., Shi, S., Kitayama, H., Takahashi, C., Noda, M. and Stetler-Stevenson, W. G. : Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK. Cancer Res. 64, 9062 (2004). DOI ScienceOn |
5 | Guedez, L., Rivera, A. M., Salloum, R., Miller, M. L., Diegmueller, J. J., Bungay, P. M. and Stetler-Stevenson, W. G. : Quantitative assessment of angiogenic responses by the directed in vivo angiogenesis assay. Am. J. Pathol. 162, 1431 (2003). DOI ScienceOn |
6 | Seo, D. W., Li, H., Qu, C. K., Oh, J., Kim, Y. S., Diaz, T., Wei, B. Y., Han, J. W. and Stetler-Stevenson, W. G. : Shp-1 mediates the anti-proliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells. J. Biol. Chem. 281, 3711 (2006). DOI |
7 | Zhang, H. and Issekutz, A. C. : Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the antiangiogenic agent SU6668. Am. J. Pathol. 160, 2219 (2002). DOI ScienceOn |
8 | Wingfield, P. T., Sax, J. K., Stahl, S. J., Kaufman, J., Palmer, I., Chung, V., Corcoran, M. L., Kleiner, D. E. and Stetler- Stevenson, W. G. : Biophysical and functional characterization of full-length, recombinant human tissue inhibitor of metalloproteinases-2 (TIMP-2) produced in Escherichia coli. Comparison of wild type and amino-terminal alanine appended variant with implications for the mechanism of TIMP functions. J. Biol. Chem. 274, 21362 (1999). DOI |
9 | Murphy, A. N., Unsworth, E. J. and Stetler-Stevenson, W. G. : Tissue inhibitor of metalloproteinases-s inhibits bFGF-induced human microvascular endothelial cell proliferation. J. Cell. Physiol. 157, 351 (1993). DOI ScienceOn |
10 | Chang, Z., Choon, A. and Friedl, A. : Endostatin binds to blood vessels in situ independent of heparan sulfate and does not compete for fibroblast growth factor-2 binding. Am. J. Pathol. 155, 71 (1999). DOI ScienceOn |
11 | Schwartz, M. A. : Integrin signaling revisited. Trends Cell Biol. 11, 466 (2001). DOI ScienceOn |
12 | Hynes, R. O. : Integrins: bidirectional, allosteric signaling machines. Cell 110, 673 (2002). DOI ScienceOn |
13 | Nyberg, P., Xie, L. and Kalluri, R. : Endogenous inhibitors of angiogenesis. Cancer Res. 65, 3967 (2005). DOI ScienceOn |
14 | Dixelius, J., Cross, M., Matsumoto, T., Sasaki, T., Timpl, R. and Claesson-Welsh, L. : Endostatin regulates endothelial cell adhesion and cytoskeletal organization. Cancer Res. 62, 1944 (2002). |
15 | Marneros, A. G. and Olsen, B. R. : Physiological role of collagen XVIII and endostatin. FASEB J. 19, 716 (2005). DOI ScienceOn |
16 | Lee, S. J., Jang, J. W., Kim, Y. M., Lee, H. I., Jeon, J. Y., Kwon, Y. G. and Lee, S. T. : Endostatin binds to the catalytic domain of matrix metalloproteinase-2. FEBS Lett. 519, 147 (2002). DOI ScienceOn |
17 | Wickstrom, S. A., Alitalo, K. and Keski-Oja, J. : An endostatin-derived peptide interacts with integrins and regulates actin cytoskeleton and migration of endothelial cells. J. Biol. Chem. 279, 20178 (2004). DOI ScienceOn |
18 | Kim, Y. M., Hwang, S., Kim, Y. M., Pyun, B. J., Kim, T. Y., Lee, S. T., Gho, Y. S. and Kwon, Y. G. : Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J. Biol. Chem. 277, 27872 (2002). DOI ScienceOn |
19 | Folkman, J. : Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action. Exp. Cell Res. 312, 594 (2006). DOI ScienceOn |
20 | Carmeliet, P. : Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389 (2000). DOI ScienceOn |
21 | Carmeliet, P. and Jain, R. K. : Angiogenesis in cancer and other diseases. Nature 407, 249 (2000). DOI ScienceOn |
22 | Blagosklonny, M. V. : Antiangiogenic therapy and tumor progression. Cancer. Cell. 5, 13 (2004). DOI ScienceOn |
23 | Sternlicht, M. D. and Werb, Z. : How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell. Dev. Biol. 17, 463 (2001). DOI ScienceOn |
24 | Stetler-Stevenson, W. G. : Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci. Signal. 1, re6 (2008). DOI ScienceOn |
25 | Stetler-Stevenson, W. G. : Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J. Clin. Invest. 103, 1237 (1999). DOI ScienceOn |
26 | Baker, A. H., Edwards, D. R. and Murphy, G. : Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 115, 3719 (2002). DOI ScienceOn |
27 | Seo, D. W., Li, H., Guedez, L., Wingfield, P. T., Diaz, T., Salloum, R., Wei, B. Y. and Stetler-Stevenson, W. G. : TIMP-2 mediated inhibition of angiogenesis : an MMP-independent mechanism. Cell. 114, 171 (2003). DOI ScienceOn |
![]() |